Victory Capital Management’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-473
| Closed | -$326K | – | 2755 |
|
|
2021
Q1 | $326K | Sell |
473
-42,339
| -99% | -$29.2M | ﹤0.01% | 2368 |
|
|
2020
Q4 | $31.6M | Buy |
42,812
+5,669
| +15% | +$4.19M | 0.04% | 691 |
|
|
2020
Q3 | $25.8M | Buy |
37,143
+36,750
| +9,351% | +$25.5M | 0.03% | 684 |
|
|
2020
Q2 | $333K | Buy |
393
+159
| +68% | +$135K | ﹤0.01% | 2135 |
|
|
2020
Q1 | $84K | Buy |
+234
| New | +$84K | ﹤0.01% | 2592 |
|
|
2019
Q4 | – | Sell |
-51
| Closed | -$6K | – | 2723 |
|
|
2019
Q3 | $6K | Buy |
+51
| New | +$6K | ﹤0.01% | 3404 |
|